Responses
Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
504 PVRIG, a novel T cell checkpoint, is preferentially expressed in TLS on stem-like memory T cells, potentially inhibiting their expansion
Compose a Response to This Article
Other responses
No responses have been published for this article.